These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19834296)

  • 1. [A case of autoimmune hepatitis which worsened after switching from a brand name to a generic version of prednisolone].
    Kakizaki S; Suzuki H; Ichikawa T; Sato K; Takagi H; Mori M; Yuasa K
    Nihon Shokakibyo Gakkai Zasshi; 2009 Oct; 106(10):1488-93. PubMed ID: 19834296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
    Margolese HC; Wolf Y; Desmarais JE; Beauclair L
    Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Administration of Saireito Enabled the Withdrawal of Corticosteroids in an Elderly Woman with Autoimmune Hepatitis.
    Fukunishi S; Nishida S; Nakamura K; Yokohama K; Ohama H; Asai A; Tsuda Y; Higuchi K
    Intern Med; 2016; 55(1):43-7. PubMed ID: 26726084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to Corticosteroid.
    Miyake Y; Sakaguchi K; Tanaka H; Nakamura S; Kobayashi Y; Fujioka S; Iwasaki Y; Shiratori Y
    Intern Med; 2005 Sep; 44(9):949-53. PubMed ID: 16258209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study.
    Engelkes M; van Blijderveen JC; Overbeek JA; Kuiper J; Herings RCM; Sturkenboom MCJM; de Jongste JC; Verhamme KMC; Janssens HM
    J Asthma; 2018 Oct; 55(10):1086-1094. PubMed ID: 29185812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevated alanine aminotransferase in a four-year-old as an early sign of autoimmune hepatitis].
    Jørgensen MH; Christensen VB; Clemmesen O
    Ugeskr Laeger; 2014 Apr; 176(8):. PubMed ID: 25096468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
    Giannakopoulos G; Verbaan H; Friis-Liby IL; Sangfelt P; Nyhlin N; Almer S;
    Dig Liver Dis; 2019 Feb; 51(2):253-257. PubMed ID: 30389427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of generic-only drug benefits on seniors' medication use and financial burden.
    Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
    Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cutaneous adverse reaction to drug excipient following brand-to-generic switch of levetiracetam.
    Lim JA; Jamil A; Ramli NA; Johar FM; Nor M
    Am J Health Syst Pharm; 2024 Jan; 81(3):e69-e72. PubMed ID: 37864830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program.
    Witt DM; Tillman DJ; Evans CM; Plotkin TV; Sadler MA
    Pharmacotherapy; 2003 Mar; 23(3):360-8. PubMed ID: 12627935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases.
    Kanda T; Yokosuka O; Hirasawa Y; Imazeki F; Nagao K; Suzuki Y; Saisho H
    Hepatogastroenterology; 2005; 52(64):1233-5. PubMed ID: 16001669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brand name versus generic warfarin: a systematic review of the literature.
    Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
    Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
    Izumi T; Hori S; Satoh H; Miki A; Sawada Y
    Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brand-to-generic oxcarbazepine switch - A prospective observational study.
    Bosak M; Słowik A; Dziedzic T
    Epilepsy Res; 2019 Mar; 151():75-77. PubMed ID: 30836239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.